From October 1, 2023 to December 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 997,406 shares, representing 1.95% for $75 million under the buyback announced on August 10, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.73 USD | -0.54% | -2.89% | -3.25% |
06-18 | Haemonetics Corporation Launches Limited Market Release of its New VASCADE MVP XL Mid-Bore Venous Closure Device | CI |
06-12 | Haemonetics Shares Rise After Upgrade From Needham | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.25% | 4.22B | |
-5.60% | 181B | |
-4.45% | 101B | |
-4.15% | 67.54B | |
-8.63% | 45.09B | |
+9.70% | 44.37B | |
+6.13% | 40.7B | |
+15.22% | 29.85B | |
+14.80% | 24.49B | |
-6.46% | 23.99B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Tranche Update on Haemonetics Corporation's Equity Buyback Plan announced on August 10, 2022.